Balyasny Asset Management
LFMD icon

Balyasny Asset Management’s LifeMD LFMD Stock Holding History

Balyasny Asset Management’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,423
Closed -$51.6K – 3065
2024
Q4 		$51.6K Buy
+10,423
New +$54.6K ﹤0.01% 2635
2024
Q3 		– Sell
-83,478
Closed -$573K – 2970
2024
Q2 		$573K Sell
83,478
-5,888
-7% -$53.9K ﹤0.01% 2007
2024
Q1 		$919K Sell
89,366
-3,492
-4% -$25.8K ﹤0.01% 1825
2023
Q4 		$770K Sell
92,858
-7,985
-8% -$57.4K ﹤0.01% 1790
2023
Q3 		$630K Hold
100,843
– – ﹤0.01% 1687
2023
Q2 		$439K Buy
+100,843
New +$224K ﹤0.01% 1890

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Balyasny Asset Management's LFMD Position: Q1 2025 in Review

Balyasny Asset Management sold out of LifeMD (LFMD) in Q1 2025, closing a stake of 10,423 shares — an estimated $51.6K sold.

Balyasny Asset Management first reported a position in LFMD in Q2 2023 and held it in 6 quarters. The position peaked at $919K in Q1 2024. 103 funds tracked by Wall St. Rank hold LFMD as of Q1 2025.

  • Balyasny Asset Management reported no remaining LifeMD position as of Q1 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 10,423 LifeMD shares in Q1 2025, an estimated $51.6K.
  • Balyasny Asset Management first reported a position in LifeMD in Q2 2023 and held it in 6 quarters.
  • Balyasny Asset Management's LifeMD position peaked at $919K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held LifeMD as of Q1 2025.

Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.